-Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH Topical Solution for the Treatment of Molluscum on October 11, 2023

Press/Media

Period28 Sep 2023

Media coverage

2

Media coverage

  • Title-Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH Topical Solution for the Treatment of Molluscum on October 11, 2023
    Media name/outletM2 PressWIRE
    Country/TerritoryUnited States
    Date28/09/23
    PersonsMichael Cameron, Mark Kaufmann
  • Title-Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH Topical Solution for the Treatment of Molluscum on October 11, 2023
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date28/09/23
    PersonsMichael Cameron, Mark Kaufmann